Maharajgunj Medical Campus
Kathmandu, Nepal
NCT Number: NCT07088575
Recent studies from Asia have reported a wide variation in the incidence of deep vein thrombosis (DVT), ranging from 5% to 50% in patients undergoing major abdominal surgery. However, data specific to the Nepalese population remains unavailable. This study aims to evaluate current thromboprophylaxis practices and determine the incidence of DVT in Nepalese adults undergoing gastrointestinal and hepatobiliary surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Kathmandu, Nepal
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
major gastrointestinal or hepatobiliary surgery under general anesthesia
Time frame: From date of surgery until hospital discharge or up to 30 days postoperatively, whichever occurs first
This outcome assesses the proportion of patients receiving appropriate thromboprophylaxis, as well as the incidence of deep vein thrombosis (DVT) among individuals undergoing major gastrointestinal and hepatobiliary surgeries. Data will be collected to evaluate adherence to prophylaxis guidelines and to determine the effectiveness of thromboprophylactic measures in preventing DVT in this surgical population.
Maharajgunj Medical Campus
Other
Practice of Deep Venous Thrombosis Prophylaxis and Its Incidence in Patients Undergoing Gastrointestinal and Hepatobiliary Surgery: A Nepalese Single-center, Retrospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07527286
Bloating, Butyrate
Canfield, Ohio, United States
View Trial DetailsNCT07179965
Behavior, Behavior, Animal
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT01386697
Breast Cancer, Breast Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT01849991
Behavior, Carbohydrate Metabolism, Inborn Errors
Houston, Texas, United States
View Trial Details